Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 23 | Longs Won 3/14 21% | Profit Factor 0.73 |
| Profitability | Shorts Won 1/9 11% | Standard Deviation $12,462.76 |
| Average Win $17,547.53 | Best Trade (Jul 17) $44,160.16 | Sharpe Ratio -30.9 |
| Average Loss -$5,087.83 | Worst Trade (Feb 18) -$20,674.43 | Z-Score -1.62 (90.44%) |
| Commissions $0 | Avg. Trade Length 2m 4d | Expectancy -$1,151.24 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 14 | 13 | 12 | 10 | 9 | 7 | 6 | 4 | 3 | 1 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
MRNA Moderna, Inc. | -1,019.5 | $51,232.99 | $56,893.29 | - | -$5,660.3 | -11.05% | +0.315% |